Euglycemic

This is an overview of Type 2 Diabetes (T2D) and Low-Carbohydrate Diets (LCDs). It is meant to stimulate thought and encourage the viewer to learn how to think about type 2 diabetes. Statistics about T2D: https://diabetesjournals.org/diabetes/article/51/12/3353/34264/The-Rise-of-Childhood-Type-1-Diabetes-in-the-20th https://diabetes.org/about-diabetes/statistics/about-diabetes Robert W Stout; Hyperinsulinemia and Atherosclerosis. Diabetes 1 July 1996; 45 (Supplement_3): S45–S46. https://doi.org/10.2337/diab.45.3.S45 ACCORD trial: https://www.nejm.org/doi/full/10.1056/nejmoa0802743 Meta-analysis: https://www.bmj.com/content/343/bmj.d4169 Atkins: https://www.atkins.com/how-it-works Dr. Richard Bernstein: https://www.diabetes-book.com/ ADA claims it is a progressive illness: https://diabetes.org/living-with-diabetes/type-2/how-type-2-diabetes-progresses#:~:text=Diabetes%20is%20considered%20a%20progressive,not%20stay%20effective%20long%2Dterm. DISCLAIMER: THIS PRESENTATION DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images, and other material contained in this presentation are for informational purposes only. No material in this presentation is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before starting a new health care regimen. Never disregard professional medical advice or delay in seeking it because of any of the information contained in this presentation.

Decide for yourself if evolocumab might benefit you. This video explores the drug manufacturer's data including some studies paid for by the manufacturer. As always, discuss with your provider the health plan that will work best for you.